Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 23 Oct 2015 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.
- 23 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.